Biogen Inc (BIIB)
Quick ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 1,049,900 | 3,419,300 | 2,261,400 | 1,331,200 | 2,913,700 |
Short-term investments | US$ in thousands | 416,800 | 2,264,600 | 2,589,600 | 1,278,900 | 1,562,200 |
Receivables | US$ in thousands | 1,664,100 | 1,705,000 | 1,549,400 | 1,913,800 | 1,880,500 |
Total current liabilities | US$ in thousands | 3,434,300 | 3,272,800 | 4,298,200 | 3,742,200 | 4,863,800 |
Quick ratio | 0.91 | 2.26 | 1.49 | 1.21 | 1.31 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($1,049,900K
+ $416,800K
+ $1,664,100K)
÷ $3,434,300K
= 0.91
The quick ratio of Biogen Inc has exhibited fluctuations over the past five years. The quick ratio was 1.26 at the end of 2023, indicating that the company had $1.26 of liquid assets available to cover each $1 of current liabilities. This represents a decrease from the prior year when the quick ratio was 2.58.
A quick ratio above 1 indicates that the company has an adequate level of liquid assets to cover its short-term obligations. Although the quick ratio of 1.26 in 2023 is above the threshold of 1, it has decreased significantly from the previous year. This might suggest a potential decrease in the company's ability to meet its short-term liabilities using its most liquid assets.
It is important to assess the reasons behind this decrease in the quick ratio and analyze the company's liquidity position comprehensively to understand the implications for its financial health and ability to meet its short-term obligations effectively.
Peer comparison
Dec 31, 2023